☆ 4.7 Article

Metagenomic Next-Generation Sequencing of Plasma for Diagnosis of COVID-19-Associated Pulmonary Aspergillosis

JOURNAL OF CLINICAL MICROBIOLOGY (2023)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Review Infectious Diseases

Defining COVID-19-associated pulmonary aspergillosis: systematic review and meta-analysis

Ruwandi M. Kariyawasam et al.

Summary: The prevalence, diagnosis, treatment, and outcomes of COVID-19-associated pulmonary aspergillosis (CAPA) are poorly understood, and there are discordant definitions across studies, potentially leading to an overestimation of reported prevalence.

CLINICAL MICROBIOLOGY AND INFECTION (2022)

添加到收藏夹

Article Microbiology

Combination of Mycological Criteria: a Better Surrogate to Identify COVID-19-Associated Pulmonary Aspergillosis Patients and Evaluate Prognosis?

Sarah Delliere et al.

Summary: This study aimed to evaluate the application of multiple mycological criteria and their combination in the diagnosis of COVID-19-associated pulmonary aspergillosis (CAPA). The results showed that direct examination, plasma PCR, and serum galactomannan were associated with a higher mortality rate. Galactomannan in bronchoalveolar lavage and positive respiratory sample culture were often found as isolated markers and had poor repeatability. A combination of markers and/or blood biomarkers and/or direct respiratory sample examination seemed to be more effective in identifying CAPA patients.

JOURNAL OF CLINICAL MICROBIOLOGY (2022)

添加到收藏夹

Article Microbiology

Aspergillus Lateral Flow Assay with Digital Reader for the Diagnosis of COVID-19-Associated Pulmonary Aspergillosis (CAPA): a Multicenter Study

Brice Autier et al.

Summary: This multicenter study evaluated the performance of the IMMY Aspergillus Galactomannan Lateral Flow Assay (LFA) for the diagnosis of pulmonary aspergillosis in patients with COVID-19-related acute respiratory failure, showing good sensitivity when used from respiratory samples but limited sensitivity in serum, possibly due to weak invasiveness during CAPA. Further mycological investigations are recommended for isolated results slightly above the cutoff.

JOURNAL OF CLINICAL MICROBIOLOGY (2022)

添加到收藏夹

Article Immunology

Coronavirus Disease 2019-Associated Pulmonary Aspergillosis in Mechanically Ventilated Patients

Nitipong Permpalung et al.

Summary: COVID-19-associated pulmonary aspergillosis (CAPA) is a serious condition in critically ill patients. A retrospective cohort study was conducted on mechanically ventilated adult patients with COVID-19, and it was found that CAPA is associated with underlying pulmonary vascular and liver diseases. Patients with CAPA have worse outcomes, requiring longer time for improvement and longer hospital stays.

CLINICAL INFECTIOUS DISEASES (2022)

添加到收藏夹

Article Dermatology

Systemic antifungal therapy with isavuconazonium sulfate or other agents in adults with invasive mucormycosis or invasive aspergillosis (non-fumigatus): A multicentre, non-interventional registry study

George R. Thompson et al.

Summary: This study aimed to determine all-cause mortality and safety outcomes among adults with invasive mucormycosis (IM) and/or non-fumigatus invasive aspergillosis (IA-nf) treated with ISAVUSULF or other antifungal therapies. The results support the effectiveness and tolerability of ISAVUSULF in clinical practice, and further research is needed to confirm the value of ISAVUSULF combination therapy over monotherapy.

MYCOSES (2022)

添加到收藏夹

Article Critical Care Medicine

Fungal infections in mechanically ventilated patients with COVID-19 during the first wave: the French multicentre MYCOVID study

Jean-Pierre Gangneux et al.

Summary: This study demonstrates a high prevalence of invasive pulmonary aspergillosis and candidemia in mechanically ventilated patients with severe COVID-19, and a high mortality associated with pr/pb CAPA. These findings highlight the importance of active surveillance for fungal pathogens in patients with severe COVID-19.

LANCET RESPIRATORY MEDICINE (2022)

添加到收藏夹

Article Infectious Diseases

Risk factors and outcome of pulmonary aspergillosis in critically ill coronavirus disease 2019 patients-a multinational observational study by the European Confederation of Medical Mycology

Juergen Prattes et al.

Summary: Coronavirus disease 2019 (COVID-19)-associated pulmonary aspergillosis (CAPA) is a common complication among critically ill COVID-19 patients in ICU. It is more prevalent in older patients, those receiving invasive ventilation, and those receiving tocilizumab treatment. CAPA is an independent predictor of ICU mortality.

CLINICAL MICROBIOLOGY AND INFECTION (2022)

添加到收藏夹

Review Infectious Diseases

When to change treatment of acute invasive aspergillosis: an expert viewpoint

Monica A. Slavin et al.

Summary: Invasive aspergillosis is an acute infection that primarily affects immunocompromised patients. When primary treatment fails, changing antifungal therapy is recommended based on specific criteria related to mycological testing, increasing galactomannan levels, clinical deterioration, or progression of original lesions.

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2022)

添加到收藏夹

Review Pharmacology & Pharmacy

Invasive candidiasis: investigational drugs in the clinical development pipeline and mechanisms of action

Martin Hoenigl et al.

Summary: Infections caused by non-albicans Candida spp. are increasing, but the development of antifungal drugs is still progressing. The article discusses in detail the antifungal agents currently in clinical development for Candida, their mechanisms of action, and pharmacokinetic and pharmacodynamic properties. Expert opinions are provided on the potential roles of these investigational agents.

EXPERT OPINION ON INVESTIGATIONAL DRUGS (2022)

添加到收藏夹

Article Microbiology

Prognostic Impact of Bronchoalveolar Lavage Fluid Galactomannan and Aspergillus Culture Results on Survival in COVID-19 Intensive Care Unit Patients: a Post Hoc Analysis from the European Confederation of Medical Mycology (ECMM) COVID-19-Associated Pulmonary Aspergillosis Study

Daniele Roberto Giacobbe et al.

Summary: Critically ill patients with COVID-19 may develop COVID-19-associated pulmonary aspergillosis (CAPA), and positive bronchoalveolar lavage fluid (BALF) mycological tests are associated with increased 90-day mortality.

JOURNAL OF CLINICAL MICROBIOLOGY (2022)

添加到收藏夹

Letter Microbiology

Utility of Serum 1,3-β-D-Glucan Testing for Diagnosis and Prognostication in COVID-19-Associated Pulmonary Aspergillosis

Matthias Egger et al.

MICROBIOLOGY SPECTRUM (2022)

添加到收藏夹

Article Immunology

Blood Mucorales PCR to track down Aspergillus and Mucorales co-infections in at-risk hematology patients: A case-control study

Robina Aerts et al.

Summary: Serum Mucorales PCR can be used as a non-invasive screening tool for the early diagnosis of invasive mucormycosis. This study highlights the underestimated incidence of Mucorales co-infections in patients with invasive aspergillosis and emphasizes the importance of considering the possibility of dual mold infections.

FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2022)

添加到收藏夹

Review Microbiology

COVID-19-associated fungal infections

Martin Hoenigl et al.

Summary: Invasive fungal infections associated with COVID-19 are an important complication, primarily caused by Aspergillus, Mucorales, and Candida species. This review examines the incidence of these fungal infections in different income countries, evaluating their epidemiology, clinical risk factors, and pathogenesis for future research and clinical guidance. Hoenigl and colleagues provide an overview of the epidemiology, immunology, and clinical risk factors of COVID-19-associated fungal infections.

NATURE MICROBIOLOGY (2022)

添加到收藏夹

Article Immunology

Pathogen Detection by Metagenomic Next-Generation Sequencing During Neutropenic Fever in Patients With Hematological Malignancies

Eduard Schulz et al.

Summary: This study validated the high sensitivity and broader pathogen spectrum of mNGS in detecting pathogens in patients with febrile neutropenia. The consistency between blood culture (BC) and mNGS was relatively low.

OPEN FORUM INFECTIOUS DISEASES (2022)

添加到收藏夹

Article Critical Care Medicine

Lung epithelial and myeloid innate immunity in influenzaassociated or COVID-19-associated pulmonary aspergillosis: an observational study

Simon Feys et al.

Summary: This study revealed a three-level breach in antifungal immunity in IAPA and CAPA, affecting the integrity of the epithelial barrier, the capacity to phagocytise and kill Aspergillus spores, and the ability to destroy Aspergillus hyphae, which is mainly mediated by neutrophils.

LANCET RESPIRATORY MEDICINE (2022)

添加到收藏夹

Article Immunology

Clinical Impact of Metagenomic Next-Generation Sequencing of Plasma Cell-Free DNA for the Diagnosis of Infectious Diseases: A Multicenter Retrospective Cohort Study

Catherine A. Hogan et al.

Summary: This retrospective cohort study evaluated the clinical impact of plasma mNGS (Karius test) in routine practice, showing limited real-world impact with only a small percentage of cases having positive effect on patient management. Further studies are needed to define high-yield patient populations and integrate mNGS into current testing algorithms effectively.

CLINICAL INFECTIOUS DISEASES (2021)

添加到收藏夹

Article Immunology

Performance of the Bronchoalveolar Lavage Fluid Aspergillus Galactomannan Lateral Flow Assay With Cube Reader for Diagnosis of Invasive Pulmonary Aspergillosis: A Multicenter Cohort Study

Jeffrey D. Jenks et al.

Summary: The study demonstrated that the Aspergillus Galactomannan Lateral Flow Assay showed good diagnostic performance for invasive aspergillosis, and its performance was consistent across different patient cohorts and centers.

CLINICAL INFECTIOUS DISEASES (2021)

添加到收藏夹

Article Immunology

A National Strategy to Diagnose Coronavirus Disease 2019-Associated Invasive Fungal Disease in the Intensive Care Unit

P. Lewis White et al.

Summary: Invasive fungal disease is common in critically ill COVID-19 patients, with 26.7% incidence rate including 14.1% aspergillosis and 12.6% yeast infections. Mortality rates are reduced with antifungal therapy, while corticosteroid use and history of chronic respiratory disease increase the likelihood of aspergillosis. Strategic diagnostic screening and antifungal prophylaxis may enhance the management of COVID-19 patients.

CLINICAL INFECTIOUS DISEASES (2021)

添加到收藏夹

Article Pharmacology & Pharmacy

The Antifungal Pipeline: Fosmanogepix, Ibrexafungerp, Olorofim, Opelconazole, and Rezafungin

Martin Hoenigl et al.

Summary: The epidemiology of invasive fungal infections is changing due to increased usage of antifungal agents leading to resistance. Limited therapeutic options are further challenged by drug-drug interactions, toxicity, and administration constraints. Despite the lack of new antifungal drug classes in the past two decades, there are promising new classes in late-stage clinical development, offering hope for improved treatment options.

DRUGS (2021)

添加到收藏夹

Review Medicine, General & Internal

Aspergillus Infections

George R. Thompson et al.

Summary: Aspergillosis is an opportunistic fungal infection that poses a particular risk for patients with neutrophil defects and causes diverse clinical syndromes. This review discusses current understanding and advances in diagnosis and treatment of aspergillosis.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

添加到收藏夹

Letter Critical Care Medicine

Diagnosis and treatment of COVID-19 associated pulmonary apergillosis in critically ill patients: results from a European confederation of medical mycology registry

Juergen Prattes et al.

INTENSIVE CARE MEDICINE (2021)

添加到收藏夹

Article Microbiology

Aspergillus Test Profiles and Mortality in Critically Ill COVID-19 Patients

Mehmet Ergun et al.

Summary: Literature on COVID-19-associated pulmonary aspergillosis has conflicting observations, with some CAPA patients surviving without antifungal therapy and discrepancies between CAPA diagnosis and autopsy findings. A case-control study was conducted comparing Aspergillus test profiles in CAPA patients and controls. The study showed that positive serum GM and BDG were associated with increased mortality in CAPA patients, highlighting the need for biomarkers to differentiate between respiratory tract colonization and tissue-invasive CAPA disease.

JOURNAL OF CLINICAL MICROBIOLOGY (2021)

添加到收藏夹

Article Immunology

Multinational Observational Cohort Study of COVID-19-Associated Pulmonary Aspergillosis1

Nico A. F. Janssen et al.

Summary: An observational study found an incidence of 10%-15% of coronavirus-disease associated pulmonary aspergillosis in intensive care units, with several factors independently associated with the disease in one cohort and mortality rates ranging from 43%-52%.

EMERGING INFECTIOUS DISEASES (2021)

添加到收藏夹

Review Infectious Diseases

Defining and managing COVID-19-associated pulmonary aspergillosis: the 2020 ECMM/ISHAM consensus criteria for research and clinical guidance

Philipp Koehler et al.

LANCET INFECTIOUS DISEASES (2020)

添加到收藏夹

Article Microbiology

Analytical and clinical validation of a microbial cell-free DNA sequencing test for infectious disease

Timothy A. Blauwkamp et al.

NATURE MICROBIOLOGY (2019)

添加到收藏夹

Article Infectious Diseases

Liquid biopsy for infectious diseases: sequencing of cell-free plasma to detect pathogen DNA in patients with invasive fungal disease

David K. Hong et al.

DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2018)

添加到收藏夹

Review Chemistry, Medicinal

Spotlight on isavuconazole in the treatment of invasive aspergillosis and mucormycosis: design, development, and place in therapy

Jeffrey D. Jenks et al.

DRUG DESIGN DEVELOPMENT AND THERAPY (2018)

添加到收藏夹

Article Microbiology

Progressive Dispersion of Azole Resistance in Aspergillus fumigatus: Fatal Invasive Aspergillosis in a Patient with Acute Myeloid Leukemia Infected with an A. fumigatus Strain with a cyp51A TR46 Y121F M172I T289A Allele

Susann Roessler et al.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2017)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.